History of blood transfusion before 1990 is a risk factor for stroke and cardiovascular diseases: The Japan Collaborative Cohort Study (JACC Study)

Cerebrovascular Diseases

Volumn 20, Issue 3, 2005, Pages 164-171

  Yamada, Shigeki ^a   Koizumi, Akio ^a   Iso, Hiroyasu ^b   Wada, Yasuhiko ^c   Watanabe, Yoshiyuki ^d   Date, Chigusa ^e   Yamamoto, Akio ^f   Kikuchi, Shogo ^g   Inaba, Yutaka ^h   Kondo, Takaaki ⁱ   Toyoshima, Hideaki ^j   Tamakoshi, Akiko ^j  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^f Hyogo Prefectural Institute of Public Health and Environmental Sciences   (Japan)

^g AICHI MEDICAL UNIVERSITY   (Japan)

^h JUNTENDO UNIVERSITY   (Japan)

ⁱ NAGOYA UNIVERSITY   (Japan)

^j NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Coronary heart disease; Epidemiology; Follow up study; Stroke; Transfusion history

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMMUNITY; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; STROKE;

ADULT; AGED; BLOOD TRANSFUSION; CEREBROVASCULAR DISORDERS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 24344493374     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087200     Document Type: Article

References (43)

1. Yamada S, Koizumi A, Iso H, Wada Y, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, Kondo T, Tamakoshi A: Risk factors for fatal subarachnoid hemorrhage: the Japan Collaborative Cohort Study. Stroke 2003;34:2781-2787.
2. Bordin JO, Heddle NM, Blajchman MA: Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994;84:1703-1721.
3. Blajchman MA, Bordin JO: Mechanisms of transfusion-associated immunosuppression. Curr Opin Hematol 1994;1:457-461.
4. Blumberg N, Heal JM: Immunological tolerance. Science 1996;272:1408.
5. Blumberg N, Heal JM: Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am J Med 1996;101:299-308.
6. Brand A: Immunological aspects of blood transfusions. Blood Rev 2000;14:130-144.
7. Chang H, Hall GA, Geerts WH, Greenwood C, McLeod RS, Sher GD: Allogeneic red blood cell transfusion is an independent risk factor for the development of postoperative bacterial infection. Vox Sang 2000;78:13-18.
8. Heiss MM, Mempel W, Jauch KW, Delanoff C, Mayer G, Mempel M, Eissner HJ, Schildberg FW: Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993;342:1328-1333.
9. Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP: Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 2003;54:908-914.
10. Klein HG: Immunomodulatory aspects of transfusion: a once and future risk? Anesthesiology 1999;91:861-865.
11. Landers DF, Hill GE, Wong KC, Fox IJ: Blood transfusion-induced immunomodulation. Anesth Analg 1996;82:187-204.
12. Leal-Noval SR, Rincon-Ferrari MD, Garcia-Curiel A, Herruzo-Aviles A, Camacho-Larana P, Garnacho-Montero J, Amaya-Villar R: Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001;119:1461-1468.
13. Tartter PI: Blood transfusion history in colorectal cancer patients and cancer-free controls. Transfusion 1988;28:593-596.
14. Vamvakas EC: Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion 1995;35:760-768.
15. Vamvakas EC: Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials. Transfusion 1996;36:175-186.
16. Vamvakas EC: WBC-containing allogeneic blood transfusion and mortality: a meta-analysis of randomized controlled trials. Transfusion 2003;43:963-973.
17. Woolley AL, Hogikyan ND, Gates GA, Haughey BH, Schechtman KB, Goldenberg JL: Effect of blood transfusion on recurrence of head and neck carcinoma. Retrospective review and meta-analysis. Ann Otol Rhinol Laryngol 1992;101:724-730.
18. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, Victor A, Hafner G, Schlumberger W, Meyer J: Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002;105:15-21.
19. Hamann GF, Zachoval R, Von Einsiedel H, Sander D: Hepatitis-C-associated multiple arterial dissection of cerebral vessels. Eur Neurol 2003;49:180-182.
20. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, Xu Q, Wick G, Poewe W, Willeit J: Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001;103:1064-1070.
21. Kiechl S, Werner P, Egger G, Oberhollenzer F, Mayr M, Xu Q, Poewe W, Willeit J: Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis: prospective results from the Bruneck Study. Stroke 2002;33:2170-2176.
22. Kunze AK, Annecke A, Wigger F, Lichy C, Buggle F, Schnippering H, Schnitzler P, Grau AJ: Recent infection as a risk factor for intracerebral and subarachnoid hemorrhages. Cerebrovasc Dis 2000;10:352-358.
23. Libby P, Egan D, Skarlatos S: Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997;96:4095-4103.
24. Lindsberg PJ, Grau AJ: Inflammation and infections as risk factors for ischemic stroke. Stroke 2003;34:2518-2532.
25. Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL, Fedeli G, Gasbarrini G, Maseri A: Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 1998;97:1675-1679.
26. Ohno Y, Tamakoshi A: Japan collaborative cohort study for evaluation of cancer risk sponsored by Monbusho (JACC Study). J Epidemiol 2001;11:144-150.
27. Iso H, Date C, Yamamoto A, Toyoshima H, Tanabe N, Kikuchi S, Kondo T, Watanabe Y, Wada Y, Ishibashi T, Suzuki H, Koizumi A, Inaba Y, Tamakoshi A, Ohno Y: Perceived mental stress and mortality from cardiovascular disease among Japanese men and women: the Japan Collaborative Cohort Study for Evaluation of Cancer Risk Sponsored by Monbusho (JACC Study). Circulation 2002;106: 1229-1236.
28. Japanese Red Cross Non-A, Non-B Hepatitis Research Group: Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Lancet 1991;338:1040-1041.
29. Lee TH, Paglieroni T, Ohto H, Holland PV, Busch MP: Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood 1999;93:3127-3139.
30. Blomberg J, Moller T, Olsson H, Anderson H, Jonsson M: Cancer morbidity in blood recipients - results of a cohort study. Eur J Cancer 1993;29A:2101-2105.
31. Cerhan JR, Wallace RB, Folsom AR, Potter JD, Munger RG, Prineas RJ: Transfusion history and cancer risk in older women. Ann Intern Med 1993;119:8-15.
32. Cerhan JR, Wallace RB, Folsom AR, Potter JD, Sellers TA, Zheng W, Lutz CT: Medical history risk factors for non-Hodgkin's lymphoma in older women. J Natl Cancer Inst 1997;89:314-318.
33. Gamba A, Mamprin F, Fiocchi R, Senni M, Troise G, Ferrazzi P, Ferrara R, Corbetta G: The risk of coronary artery disease after heart transplantation is increased in patients receiving low-dose cyclosporine, regardless of blood cyclosporine levels. Clin Cardiol 1997;20:767-772.
34. Gunji Y, Ochiai T, Sakamoto K, Suzuki T, Nagata M, Nakajima K, Komori A, Asano T, Isono K, Hamaguchi K: Pathologic characteristics of vasculitis in renal transplant recipient dogs receiving immunosuppressive agents, FK-506, rapamycin, or RS-61443. Transplant Proc 1993;25:752-753.
35. Miller LW: Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2002;2:807-818.
36. Singer DR, Jenkins GH: Hypertension in transplant recipients. J Hum Hypertens 1996;10:395-402.
37. Asai T, Inaba S, Ohio H, Osada K, Suzuki G, Takahashi K, Tadokoro K, Minami M: Guidelines for irradiation of blood and blood components to prevent post-transfusion graft-versus-host disease in Japan. Transfus Med 2000;10:315-320.
38. Van de Watering LM, Hermans J, Houbiers JG, van den Broek PJ, Bouter H, Boer F, Harvey MS, Huysmans HA, Brand A: Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998;97:562-568.
39. Wallis JP, Chapman CE, Orr KE, Clark SC, Forty JR: Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion 2002;42:1127-1134.
40. Blumberg N, Heal JM: The transfusion immunomodulation theory: the Th1/Th2 paradigm and an analogy with pregnancy as a unifying mechanism. Semin Hematol 1996;33:329-340.
41. Szekeres-Bartho J, Barakonyi A, Polgar B, Par G, Faust Z, Palkovics T, Szereday L: The role of γ/δ T cells in progesterone-mediated immunomodulation during pregnancy: a review. Am J Reprod Immunol 1999;42:44-48.
42. Sankai T, Miagaki T, Iso H: A population-based study of the proportion by type of stroke determined by computed tomography scan (in Japanese). Nippon Koshu Eisei Zasshi 1991;38:901-909.
43. Sandhu JS, Campbell PM, Preiksaitis JK, Carriere KC, Hessel PA: Validation of self-reported transfusion histories in renal dialysis patients. Can J Public Health 1999;90:201-204.